Williams Hart & Boundas, LLP has joined a team of leading plaintiffs' law firms to achieve a $7.25 billion settlement class action against Monsanto that would resolve thousands of existing and future claims involving Roundup exposure and non-Hodgkin lymphoma. The settlement, filed on February 17, 2026, by Williams Hart & Boundas, Waters Kraus Paul & Siegel, Motley Rice, Seeger Weiss, and the Holland Law Firm, in the City of St. Louis Circuit Court will establish a structured compensation framework for individuals diagnosed with NHL following exposure to Monsanto's glyphosate-based herbicide. Over the past several years, juries nationwide have returned significant verdicts linking Roundup to non-Hodgkin lymphoma, while tens of thousands of claims remain pending in state and federal courts.
According to the settlement, Monsanto will fund up to $7.25 billion to compensate a class that includes virtually all existing and certain future Roundup cancer claims. The agreement is designed to provide a structured and comprehensive resolution framework for individuals diagnosed with non-Hodgkin lymphoma following exposure to the herbicide. John Eddie Williams, Jr., Founding and Managing Partner of Williams Hart & Boundas, LLP stated, "After years of pressing cases against Monsanto and in light of the fact that the U.S. Supreme Court has accepted an appeal to review the validity of these Round-Up claims, we are pleased to achieve a resolution that we believe is acceptable based on the current circumstances." The timing of this settlement is particularly significant given the pending Supreme Court review, which could have affected the legal standing of thousands of claims.
Under the proposed settlement, eligible class members will have the right to opt out and pursue their claims individually if they choose. This massive settlement represents one of the largest product liability resolutions in recent history and provides a potential path to compensation for individuals who have developed non-Hodgkin lymphoma after using the widely available herbicide. The case is filed in St. Louis city court, where many similar claims have been consolidated. The settlement's importance extends beyond the immediate financial compensation, as it establishes a formal recognition of the connection between Roundup exposure and non-Hodgkin lymphoma through a court-approved resolution process.
This development comes after years of litigation and scientific debate about the safety of glyphosate-based products, which have been used extensively in agricultural, commercial, and residential settings worldwide. The structured framework aims to provide consistent compensation standards while potentially reducing the burden on court systems handling tens of thousands of individual claims. The settlement creates a precedent for how mass tort cases involving widely used consumer products can be resolved through comprehensive class action mechanisms rather than piecemeal litigation across multiple jurisdictions.
